Concepedia

Ken Shiozawa

KS

Statistics

Publications

16

Citations

1.5K

H-Index

15

Active since

1996

Affiliations

Nagasaki University(Current)

University of Maryland, Baltimore

Meiji Pharmaceutical University

Kawasaki Medical School

Kagoshima University

Ken Shiozawa is an author at Nagasaki University specializing in medicine, oncology, and molecular oncology.

Publications per year

1996–2013

16

Publications

16

Breast Cancer Resistance Protein Directly Confers SN-38 Resistance of Lung Cancer Cells

Shigeru Kawabata, Mikio Oka, Ken Shiozawa et al. · Biochemical and Biophysical Research Communications · 2001 · 239 citations

, , +12

Transport of 7-Ethyl-10-hydroxycamptothecin (SN-38) by Breast Cancer Resistance Protein ABCG2 in Human Lung Cancer Cells

Katsumi Nakatomi, Megumi Yoshikawa, Mikio Oka et al. · Biochemical and Biophysical Research Communications · 2001 · 188 citations

, , +12

Gefitinib (“Iressa”, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses Breast Cancer Resistance Protein/ABCG2–Mediated Drug Resistance

Yoichi Nakamura, Mikio Oka, Hiroshi Soda et al. · Cancer Research · 2005 · 177 citations · Full text

, , +15

Complex interaction of BCRP/ABCG2 and imatinib in BCR-ABL–expressing cells: BCRP-mediated resistance to imatinib is attenuated by imatinib-induced reduction of BCRP expression

Takeo Nakanishi, Ken Shiozawa, Bret A. Hassel et al. · Blood · 2006 · 150 citations · Full text

, , +7

Reversal of breast cancer resistance protein (BCRP/ABCG2)‐mediated drug resistance by novobiocin, a coumermycin antibiotic

Ken Shiozawa, Mikio Oka, Hiroshi Soda et al. · International Journal of Cancer · 2003 · 121 citations

, , +16

1–5 of 16